Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Francesca Nanì"'
Autor:
Duygu Ağagündüz, Ermelinda Cocozza, Özge Cemali, Ayşe Derya Bayazıt, Maria Francesca Nanì, Ida Cerqua, Floriana Morgillo, Suna Karadeniz Saygılı, Roberto Berni Canani, Paola Amero, Raffaele Capasso
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Gastrointestinal cancer represents one of the most diagnosed types of cancer. Cancer is a genetic and multifactorial disease, influenced by the host and environmental factors. It has been stated that 20% of cancer is caused by microorganisms such as
Externí odkaz:
https://doaj.org/article/f6e30458119248c7ba9c6970bcb644c9
Autor:
Ester Pagano, Barbara Romano, Donatella Cicia, Fabio A. Iannotti, Tommaso Venneri, Giuseppe Lucariello, Maria Francesca Nanì, Fabio Cattaneo, Paola De Cicco, Maria D'Armiento, Marcello De Luca, Ruggiero Lionetti, Stefania Lama, Paola Stiuso, Pietro Zoppoli, Geppino Falco, Silvia Marchianò, Stefano Fiorucci, Raffaele Capasso, Vincenzo Di Marzo, Francesca Borrelli, Angelo A. Izzo
Publikováno v:
British journal of pharmacologyREFERENCES. 180(2)
Background and Purpose: Transient receptor potential melastatin type-8 (TRPM8) is a cold-sensitive cation channel protein belonging to the TRP superfamily of ion channels. Here, we reveal the molecular mechanism of TRPM8 and its clinical relevance in
Autor:
Donatella Cicia, Maria D'Armiento, Alexandros Makriyannis, Tommaso Venneri, Fabio Arturo Iannotti, Michael S. Malamas, Federica Di Tella, Giovanna Vanacore, Ester Pagano, Raffaele Capasso, Barbara Romano, Fabiana Piscitelli, Angelo A. Izzo, Giovanni Aprea, Giuseppe Lucariello, Vincenzo Brancaleone, Francesca Borrelli, Bernardo Sbarro, Marcello De Luca, Vincenzo Di Marzo, Ruggero Lionetti, Maria Francesca Nanì, Ferdinando Fiorino, Rosa Sparaco
Publikováno v:
British journal of pharmacology. 179(8)
Background and purpose N-acylethanolamine acid amidase (NAAA) is a lysosomal enzyme accountable for the breakdown of N-acylethanolamides (NAEs) and its pharmacological inhibition determines beneficial effects in inflammatory conditions. The knowledge
Autor:
Barbara Romano 1 2, Ester Pagano 1 2, Fabio A Iannotti 3 2, Fabiana Piscitelli 3 2, Vincenzo Brancaleone 4, Giuseppe Lucariello 1, Maria Francesca Nanì 1 2, Ferdinando Fiorino 1, Rosa Sparaco 1, Giovanna Vanacore 1, Federica Di Tella 1, Donatella Cicia 1, Ruggero Lionetti 5, Alexandros Makriyannis 6, Michael Malamas 6, Marcello De Luca 5, Giovanni Aprea 7, Maria D'Armiento 8, Raffaele Capasso 9 2, Bernardo Sbarro 1, Tommaso Venneri 1 2, Vincenzo Di Marzo 3 10 11 2, Francesca Borrelli 1 2, Angelo A Izzo 1 2
Publikováno v:
British journal of pharmacology (2021).
info:cnr-pdr/source/autori:Barbara Romano 1 2, Ester Pagano 1 2, Fabio A Iannotti 3 2, Fabiana Piscitelli 3 2, Vincenzo Brancaleone 4, Giuseppe Lucariello 1, Maria Francesca Nanì 1 2, Ferdinando Fiorino 1, Rosa Sparaco 1, Giovanna Vanacore 1, Federica Di Tella 1, Donatella Cicia 1, Ruggero Lionetti 5, Alexandros Makriyannis 6, Michael Malamas 6, Marcello De Luca 5, Giovanni Aprea 7, Maria D'Armiento 8, Raffaele Capasso 9 2, Bernardo Sbarro 1, Tommaso Venneri 1 2, Vincenzo Di Marzo 3 10 11 2, Francesca Borrelli 1 2, Angelo A Izzo 1 2/titolo:NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth/doi:/rivista:British journal of pharmacology/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Barbara Romano 1 2, Ester Pagano 1 2, Fabio A Iannotti 3 2, Fabiana Piscitelli 3 2, Vincenzo Brancaleone 4, Giuseppe Lucariello 1, Maria Francesca Nanì 1 2, Ferdinando Fiorino 1, Rosa Sparaco 1, Giovanna Vanacore 1, Federica Di Tella 1, Donatella Cicia 1, Ruggero Lionetti 5, Alexandros Makriyannis 6, Michael Malamas 6, Marcello De Luca 5, Giovanni Aprea 7, Maria D'Armiento 8, Raffaele Capasso 9 2, Bernardo Sbarro 1, Tommaso Venneri 1 2, Vincenzo Di Marzo 3 10 11 2, Francesca Borrelli 1 2, Angelo A Izzo 1 2/titolo:NAAA is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth/doi:/rivista:British journal of pharmacology/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Background and purpose: N-acylethanolamine acid amidase (NAAA) is a lysosomal enzyme accountable for the breakdown of N-acylethanolamides (NAEs) and its pharmacological inhibition determines beneficial effects in inflammatory conditions. The knowledg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::3e4aac930f29aa874cab6dc79e2d4b1f
http://www.cnr.it/prodotto/i/460792
http://www.cnr.it/prodotto/i/460792